Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN PHARMA

23.160
+0.0800.35%
Volume:2.47M
Turnover:57.43M
Market Cap:61.58B
PE:20.39
High:23.440
Open:23.120
Low:22.740
Close:23.080
52wk High:29.000
52wk Low:12.202
Shares:2.66B
HK Float Shares:540.97M
Volume Ratio:1.48
T/O Rate:0.46%
Dividend:0.35
Dividend Rate:1.51%
EPS(LYR):1.136
ROE:6.75%
ROA:1.32%
PB:1.17
PE(LYR):20.39
PS:1.42

Loading ...

Press Release: Fosun Pharma Announces 2025 Interim Results

Dow Jones
·
Aug 26

FOSUN PHARMA (02196) Reports 2025 Interim Results with Improved Operating Cash Flow and Continued Innovation Transformation

Stock News
·
Aug 26

FOSUN PHARMA Plans Stock Incentive Program to Reinforce Innovation Transformation and Growth Confidence

Deep News
·
Aug 25

FOSUN PHARMA (02196) Plans to Launch 2025 A-Share Stock Option Incentive Program

Stock News
·
Aug 22

Hong Kong Stock Movement | FOSUN PHARMA (02196) Surges Over 6% Again as Small Molecule Oral DPP-1 Inhibitor Licensed Overseas, Supporting Revaluation of Innovative Drug Pipeline

Stock News
·
Aug 15

Innovation Gains International Recognition as AH-Listed Pharmaceutical Leader FOSUN PHARMA (02196) Poised to Unlock "Dual Value"

Stock News
·
Aug 15

FOSUN PHARMA (02196) Successfully Issues 1 Billion Yuan Medium-to-Long-Term Technology Innovation Bond, Leading Industry Development Through Innovation and Transformation

Stock News
·
Aug 14

Fosun Pharma's Unit Gets Acceptance for Tumor Drug Registration Application in China

MT Newswires Live
·
Aug 12

Fosun Pharmaceutical Sells 1 Billion Yuan Bonds; Shares Up 2%

MT Newswires Live
·
Aug 11

Fosun Pharma Gets Nod to Conduct US Trials On Thymic Carcinoma Drug

MT Newswires Live
·
Aug 08

Fosun Pharmaceutical Signs Deal With Neuracle to Buy Alzheimer's Drug Rights

MT Newswires Live
·
Jul 29

Fosun Pharmaceutical to Invest 120 Million Yuan in Nuclear Medicine Subsidiary

MT Newswires Live
·
Jul 23

HK Movers | HK's Biotech Shares Soar. Livzon Pharma up 14%; Shandong Xinhua up 11%; Fosun Pharma up 8%

Tiger Newspress
·
Jul 16

Fosun Pharma Announces Proportional Capital Reduction of Suzhou Angel Fund

Stock Track
·
Jul 15

Fosun Pharma Unit's Registration Application for Bowel Cleansing Drug Accepted by Chinese Regulator

MT Newswires Live
·
Jul 11

Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake

Dow Jones
·
Jun 26

Fosun Pharma's Respiratory Drug Receives Clinical Trial Approval for COPD Treatment in China

MT Newswires Live
·
Jun 02

Fosun Pharmaceutical Gets Chinese Regulatory Approval for Breast Cancer Drug; Shares Up 4%

MT Newswires Live
·
May 30

Fosun Pharmaceutical Gains EU Orphan Drug Status for Cancer Drug

MT Newswires Live
·
May 27